evipedia.ai
← Back

Peppermint Oil for Hair Regrowth

Evidence Review created on 09/27/2026 using AI4L / Opus 5.5

Also known as: Peppermint Essential Oil, Mentha piperita Oil, Mentha × piperita Oil, Oleum Menthae piperitae, Menthae piperitae aetheroleum

Motivation

Peppermint oil is a concentrated essential oil distilled from the peppermint plant (Mentha × piperita). Its main active compound, menthol, produces the familiar cooling tingle on the skin and briefly increases blood flow where it is applied. That sensation, and the idea that better blood supply feeds hair roots, has made peppermint oil one of the most popular home remedies for thinning hair.

Interest grew sharply after a laboratory study in mice reported that diluted peppermint oil sped up hair growth more than a standard hair-loss drug. Hair-care brands and online communities have promoted the oil widely since then. At the same time, peppermint oil is a recognized cause of skin allergy, and whether results in mice carry over to people is an open question.

This review examines the evidence for and against applying peppermint oil to the scalp to regrow hair: how it may work, what benefits and risks have been documented, how it is typically used, and how results can be tracked, for adults who want to preserve their hair as part of long-term health.

Benefits - Risks - Protocol - Conclusion

This section lists expert commentary, a podcast episode and qualifying academic articles that give a high-level overview of peppermint oil for hair regrowth.

Andrew Huberman’s hair-loss episode qualifies through the shared scalp blood-flow mechanism rather than an in-depth discussion of peppermint oil itself. No directly relevant content on peppermint oil for hair was found from Rhonda Patrick, Peter Attia, Chris Kresser, Life Extension Magazine or Lifespan.io; web and on-site searches returned only unrelated hair-loss or general mint content.

Grokipedia

Peppermint oil for hair growth

Encyclopedic overview of the hair-growth claim, tracing it largely to a single mouse study and summarizing proposed mechanisms, application practices and the absence of controlled human trials.

Examine

Peppermint benefits, dosage, and side effects

Examine’s peppermint page grades evidence for oral use in irritable bowel syndrome (a functional gut disorder) and topical 10% oil for tension headache; it lists no hair-growth outcomes.

ConsumerLab

Peppermint Oil for Irritable Bowel Syndrome (IBS): Does It Work?

ConsumerLab’s only dedicated peppermint oil article covers oral use for irritable bowel syndrome, dosing and safety; hair use appears only in its general hair-loss answer on topical essential oils.

Systematic Reviews

This section lists systematic reviews that include peppermint oil or menthol, covering its claimed hair and itch effects and its principal risk, skin reactions.

Mechanism of Action

Peppermint oil’s main constituents are menthol (about 30–55%) and menthone (14–32%), with smaller amounts of menthyl acetate, 1,8-cineole, menthofuran and pulegone.

  • Cooling-receptor activation: Menthol activates TRPM8 (transient receptor potential melastatin 8, the skin’s cold-sensing ion channel) on sensory nerves and vessels. In human skin this widens small vessels through nitric oxide (a vessel-relaxing gas), EDHF (endothelium-derived hyperpolarizing factors, relaxing signals from the vessel lining) and nerve reflexes (Craighead et al., 2017). The hair hypothesis assumes more blood reaches the dermal papilla (the signaling cell cluster at the follicle base).
  • Growth-phase signaling: In mice, 3% peppermint oil raised IGF-1 (insulin-like growth factor 1, a follicle growth signal) and ALP (alkaline phosphatase, an enzyme marking active papilla cells) and shifted follicles into anagen (the active growth phase) (Oh et al., 2014).
  • Penetration enhancement: Menthol loosens skin lipids, which may increase uptake of co-applied agents.
  • Competing view: Pattern hair loss is driven by DHT (dihydrotestosterone, a potent male hormone) shrinking follicles; peppermint oil has no known anti-androgen (male-hormone-blocking) action, and TRPM8 activation can constrict rather than widen vessels depending on baseline tone (Johnson et al., 2009).
  • Pharmacology: Topical menthol appears in skin within 30 minutes and clears by 60 minutes (Craighead et al., 2017). Absorbed menthol is conjugated by UGT enzymes (UDP-glucuronosyltransferases, which tag compounds for urinary excretion) and oxidized by CYP2A6 (a liver enzyme that oxidizes menthol); plasma half-life is roughly one hour. Selectivity is modest: at high concentrations menthol also activates TRPA1 (an irritant-sensing channel).

Historical Context & Evolution

Peppermint is a natural hybrid of watermint (Mentha aquatica) and spearmint (Mentha spicata), described in England in the late 17th century and cultivated for its oil from the 18th century. Its original uses were digestive and flavoring: mint preparations eased indigestion and colic, and the oil flavored confectionery, toothpaste and medicines. Menthol, isolated from mint oil in the 18th century, became a standard ingredient in topical pain and anti-itch preparations because of its cooling effect.

Scalp use grew out of that cooling tingle. Barbershop hair tonics and “invigorating” shampoos have long contained menthol or peppermint oil, marketed for freshness and circulation rather than as hair-loss treatments.

Interest in regrowth rose after a 2014 Korean mouse study reported that 3% peppermint oil outperformed 3% minoxidil on follicle number and depth (Oh et al., 2014). Its actual findings were thicker skin, more and deeper follicles, and higher growth-signal activity after 4 weeks, with no change in body weight. Online hair-care communities and essential-oil marketers amplified the result, and a 2015 human trial in which rosemary oil performed comparably to 2% minoxidil (Panahi et al., 2015) broadened enthusiasm for essential oils generally.

Scientific opinion has moved little since: reviews credit the mouse data while noting that no human hair trial of peppermint oil has followed (Bin Rubaian et al., 2024). New evidence has accumulated mainly on the safety side, through large patch-test registries documenting allergy (Warshaw et al., 2025).

Expected Benefits

High 🟩 🟩 🟩

Relief of Itch ⭕️ Not Central to Hair Regrowth

Topical peppermint oil reduces itch by activating the skin’s cold receptor, which dampens itch-signaling nerves. In a controlled trial of 50 adults with chronic itch from liver, kidney or diabetic disease, 5% oil outperformed petrolatum (petroleum jelly) on the 5-D itch scale (a validated five-domain itch questionnaire) (Elsaie et al., 2016); a triple-blind trial of 0.5% oil in 96 pregnant women also reduced itch (Akhavan Amjadi et al., 2012). Neither trial treated the scalp. This bears on scalp comfort, not hair growth.

Magnitude: Mean 5-D itch score fell from 15.2 to 7.9 (about 48%) over 2 weeks with 5% peppermint oil, versus 14.5 to 13.5 with petrolatum.

Relief of Tension-Type Headache ⭕️ Not Central to Hair Regrowth

A 10% peppermint oil solution spread on the forehead and temples eases tension-type headache (the common band-like, muscle-tension headache). In a double-blind crossover trial of 41 patients treating 164 attacks, it outperformed placebo within 15 minutes and matched 1,000 mg acetaminophen (Göbel et al., 1996); a review by the same group reports consistent results across controlled studies (Göbel et al., 2016). This bears on head pain, not hair growth.

Magnitude: Headache intensity was significantly lower than with placebo from 15 minutes through 1 hour (p < 0.01, meaning a difference this large would arise by chance less than 1% of the time), with efficacy equal to 1,000 mg acetaminophen; the trial abstract reports no absolute effect size.

Medium 🟩 🟩

No benefit reaches Medium: no human trial or observational study has measured any hair outcome with peppermint oil, so hair effects rest on mouse experiments and indirect human blood-flow data.

Low 🟩

Increased Skin Blood Flow

Menthol gels at 3–5% raised skin blood flow in small controlled human studies, dose-dependently, with half-maximal effect near 1% menthol (Craighead & Alexander, 2016; Dillon et al., 2022). Evidence is indirect: forearm or leg skin, pure menthol, no hair outcome.

Magnitude: Skin vascular conductance (blood flow adjusted for blood pressure) was about threefold higher with 4% menthol than placebo (3.41 vs 1.10 units) and rose about elevenfold from baseline with 5% menthol gel.

Speculative 🟨

Hair Regrowth and Growth-Phase Induction

In mice, 3% peppermint oil for 4 weeks increased follicle number and depth more than 3% minoxidil (Oh et al., 2014). No human hair trial exists; the basis is animal data only.

Enhanced Delivery of Co-Applied Minoxidil

Menthol pretreatment raised minoxidil levels in hair bulbs of mice (Goto et al., 2022). The basis is animal data only; no human hair-count data exist.

Dandruff and Scalp Microbe Control

Peppermint oil inhibits yeasts and bacteria in laboratory assays, which could matter where dandruff-related inflammation contributes to shedding. The basis is in-vitro only; no controlled scalp trials exist.

Benefit-Modifying Factors

  • Genetic predisposition: Pattern hair loss is strongly inherited through androgen-receptor (the follicle’s male-hormone sensor) and other gene variants; heavy genetic loading with advanced follicle shrinkage likely leaves fewer responsive follicles for any non-hormonal topical. No pharmacogenetic data exist for peppermint oil.
  • Baseline biomarkers: Shedding driven by low ferritin (stored iron), thyroid dysfunction or low vitamin D stems from causes peppermint oil does not correct; any benefit presumably depends on these values being normal first.
  • Sex: No sex-specific data exist. Female pattern hair loss (diffuse crown thinning) and male pattern loss differ in androgen drive; a non-hormonal oil has more relative appeal where anti-androgen drugs are unsuitable, such as around pregnancy.
  • Type of hair loss: Pattern loss, telogen effluvium (temporary stress-triggered shedding), alopecia areata (autoimmune patchy loss) and scarring alopecias differ in cause; mouse data model hair-cycle stimulation, most relevant to pattern loss and telogen effluvium.
  • Scalp condition: Dandruff, seborrheic dermatitis (a flaky, inflamed scalp condition) or scalp itch may respond to the oil’s cooling and antimicrobial actions, while eczema or psoriasis may flare with irritation, offsetting any gain.
  • Age: Older adults have more shrunken follicles and slower hair cycles, lowering expected response; thinner, drier skin at the upper end of the age range also narrows the tolerable concentration.
  • Scalp massage co-factor: Daily 4-minute standardized scalp massage alone increased hair thickness in 9 men over 24 weeks (Koyama et al., 2016), so the massage accompanying oil application may contribute to perceived effects.

Potential Risks & Side Effects

High 🟥 🟥 🟥

No risk reaches High: no controlled trial of scalp-applied peppermint oil has systematically recorded adverse events, and allergy data come from patch-test registries rather than from trials.

Medium 🟥 🟥

Allergic Contact Dermatitis

Peppermint oil constituents can sensitize the immune system, producing an itchy eczema-like rash on re-exposure. The North American Contact Dermatitis Group (a dermatologist patch-testing network with no stake in peppermint sales) found allergy in 161 of 28,128 patients tested; about 30% of reactions were strong and 83% co-reacted with other fragrance or plant allergens (Warshaw et al., 2025). Face, lips and hands were common sites; oral-care products a leading source. Reviews list peppermint oil as a recognized sensitizer (de Groot & Schmidt, 2016).

Magnitude: 0.6% of patients referred for patch testing reacted to 2% peppermint oil over 2009–2020; nearly one-third of those reactions were strong or extreme.

Low 🟥

Irritant Reactions and Burning

Undiluted or strong oil can cause stinging, redness and burning via TRPA1 activation; eye contact is especially painful. In a 74-patient trial of a peppermint oil, menthol and methyl salicylate gel, 8% developed irritation (Wu et al., 2016). Case reports dominate (Posadzki et al., 2012).

Magnitude: 8% of patients developed transient skin irritation with a combined peppermint oil gel; the frequency with diluted scalp use has not been measured.

Speculative 🟨

Systemic Toxicity from Pulegone and Menthofuran

Pulegone and menthofuran are liver toxins in animals; the Cosmetic Ingredient Review panel, funded by a cosmetics trade group whose members sell peppermint products, capped pulegone at 1% (Nair, 2001). Basis: animal data only.

Increased Absorption of Co-Applied Scalp Products

Menthol’s penetration-enhancing effect could raise absorption, and side effects, of co-applied drugs such as minoxidil (Goto et al., 2022). The basis is mechanistic and animal data only.

Forgone Benefit from Delaying Proven Treatment

Relying on peppermint oil alone during progressive pattern hair loss could allow follicles to shrink beyond recovery. The basis is mechanistic reasoning; no study has measured this.

Risk-Modifying Factors

  • Genetic barrier variants: Loss-of-function variants in FLG (the filaggrin gene, encoding a skin-barrier protein), common in eczema, weaken the skin barrier, which may ease penetration of fragrance allergens and irritants.
  • Baseline biomarkers: No blood marker predicts risk; a prior positive patch test to peppermint oil, menthol or fragrance mixes is the relevant baseline indicator of allergy.
  • Existing fragrance allergy: 83% of peppermint-allergic patients also reacted to other fragrance or plant allergens, such as Myroxylon pereirae (balsam of Peru) or fragrance mix I (Warshaw et al., 2025).
  • Sex: Women made up 77% of peppermint-allergic patch-test patients (Warshaw et al., 2025), likely reflecting greater exposure to cosmetics and lip products rather than intrinsic susceptibility.
  • Pre-existing skin disease: Scalp eczema, psoriasis, seborrheic dermatitis, sunburn or recent bleaching and relaxer treatments disrupt the barrier, raising irritation and sensitization.
  • Age: 71% of allergic patients were over 40 (Warshaw et al., 2025); aging skin is thinner and drier. Menthol near the faces of infants and young children can impair breathing (per a National Institutes of Health herb fact sheet).

Key Interactions & Contraindications

  • Prescription topical retinoids (vitamin A–derived skin drugs: tretinoin, adapalene, tazarotene): Caution. Additive barrier disruption increases scalp irritation and burning. Alternating application days reduces cumulative irritation.
  • Prescription topical corticosteroids (anti-inflammatory steroid drugs; clobetasol, betamethasone scalp solutions): Monitor. Menthol’s penetration enhancement may raise steroid absorption, adding to skin thinning with prolonged use. Separating applications by several hours limits overlap.
  • Drugs cleared by CYP3A4 (the main drug-metabolizing liver enzyme; e.g., felodipine, simvastatin, cyclosporine): Relevant only to oral peppermint oil, which raised felodipine exposure 40% (Dresser et al., 2002). Scalp use at 1–3%: monitor only.
  • Oral finasteride and dutasteride (5-alpha-reductase inhibitors, which block testosterone’s conversion to DHT): No known interaction; commonly combined without documented consequence. No mitigation needed.
  • Over-the-counter topical minoxidil: Monitor. Menthol may raise follicular minoxidil uptake (mouse data; Goto et al., 2022), possibly adding scalp irritation or systemic effects such as dizziness. Applying the two several hours apart limits overlap.
  • Over-the-counter menthol and camphor products (medicated shampoos, analgesic rubs): Caution. Stacking menthol sources increases irritation and cumulative menthol exposure. Using a single menthol source limits this.
  • Other essential oils (rosemary, tea tree, lavender, ylang-ylang): Caution. Blends multiply sensitization risk, causing allergic dermatitis to several oils. Introducing one oil at a time identifies any culprit.
  • Supplements with additive scalp-circulation effects (topical caffeine, rosemary oil): Monitor. Blood-flow effects may add, and irritation may accumulate; no harmful interaction is documented. Introducing products sequentially clarifies tolerance.
  • Microneedling and scalp procedures: Caution. Oil on freshly needled skin penetrates deeply, raising irritation and allergy risk. Waiting at least 48 hours after microneedling avoids this.

Populations who should avoid Peppermint Oil:

  • People with a positive patch test (+ or stronger) to Mentha piperita oil 2% or to menthol
  • Infants and children under 6 years, and application near their faces (risk of breathing reactions)
  • People with active scalp eczema, psoriasis flares, open wounds, or within 48 hours of microneedling or chemical hair treatments
  • People with confirmed fragrance-mix or balsam of Peru allergy (high co-reactivity; forearm testing first)
  • People with sudden patchy, rapidly progressive or scarring hair loss before a dermatological diagnosis

Risk Mitigation Strategies

  • Dilution to 1–3%: Keeping peppermint oil at 1–3% in a carrier (about 2–6 drops per 10 mL) limits irritant burning and reduces sensitization, which rises with concentration and leave-on exposure.
  • Forearm patch test: Applying the intended dilution to the inner forearm twice daily for 2–3 days before scalp use screens for allergic contact dermatitis.
  • Eye protection: Applying with fingertips away from the hairline, washing hands afterward, and avoiding application before sweating prevent painful eye irritation.
  • Rinse-off alternative: Adding 2–3 drops to a single shampoo dose shortens contact time, lowering irritation and allergy risk for sensitive scalps.
  • Fresh, tested oil: Oxidized essential oils are more allergenic; dark glass, sealed storage and use within 12 months limit oxidation-related sensitization, and composition-tested oil limits pulegone exposure.
  • Single-oil introduction: Starting peppermint oil alone before adding rosemary or other oils identifies the culprit if dermatitis develops, preventing multiple sensitizations.
  • Stop at first rash: Discontinuing at the first persistent redness, itching or blistering, followed by dermatological patch testing, prevents progression to widespread allergic dermatitis.
  • Six-month reassessment: A photographic checkpoint at 6 months limits forgone benefit, since progressive pattern hair loss can shift to approved treatments if no response appears.
  • Spacing from minoxidil and procedures: Applying peppermint oil several hours apart from minoxidil, and waiting 48 hours after microneedling, limits increased absorption and irritation.

Therapeutic Protocol

  • Standard concentration: Practitioner protocols typically dilute peppermint oil to 1–3% in a carrier oil (about 6 drops per 10 mL at 3%), mirroring the mouse study’s 3%; undiluted oil is not used.
  • Carrier and format: Jojoba, coconut or grapeseed oils are common carriers; alternatively, 2–3 drops are added to a single shampoo dose as a rinse-off method with lower leave-on exposure.
  • Application and frequency: A few milliliters of the dilution are massaged into thinning areas for 3–5 minutes, left 30 minutes to overnight, and repeated 3–7 times weekly.
  • Best time of day: No data favor a time. Evening application allows overnight contact; morning use suits the brief cooling sensation. Blood-flow effects peak roughly 15–45 minutes after application (Craighead et al., 2017).
  • Half-life: Topical menthol is detectable in skin within 30 minutes and cleared by 60 minutes (Craighead et al., 2017); absorbed menthol has a plasma half-life of roughly one hour, so nothing accumulates between daily applications.
  • Single vs split dosing: Given the short skin residence, one daily application is the norm; twice-daily use has no supporting data and doubles irritation exposure.
  • Standalone natural approach: Promoted in aromatherapy and natural hair-care communities for its tingling, blood-flow rationale; Andrew Huberman mentions it only in passing, as something some people suggest for scalp blood flow.
  • Add-on approach: Hair-loss commentators such as the Perfect Hair Health team frame peppermint oil as, at most, an add-on to evidence-backed treatments, given the absence of human data.
  • Conventional approach: Dermatology practice centers on minoxidil and finasteride, the drugs approved by the FDA (U.S. Food and Drug Administration) for pattern hair loss, with peppermint oil outside standard protocols.
  • Genetic factors: No pharmacogenetic data exist. Strong inherited pattern hair loss implies a smaller expected response to a non-hormonal topical; TRPM8 gene variants may alter cooling perception and tolerability.
  • Sex differences: No sex-specific dosing data exist. Because women account for 77% of peppermint-allergic patch-test patients (Warshaw et al., 2025), starting at 1% is the conservative choice; women avoiding anti-androgens around pregnancy form a large user group.
  • Age: At the older end of the adult range, thinner skin favors 1–2% dilutions and fewer weekly applications, and expected response is lower because follicles are more shrunken.
  • Baseline biomarkers: Low ferritin, thyroid dysfunction or low vitamin D cause shedding peppermint oil cannot correct; protocols assess and correct these first, since response presumably depends on them.
  • Pre-existing conditions: Scalp eczema, psoriasis or seborrheic dermatitis raise irritation risk; alopecia areata and scarring alopecias have different causes that peppermint oil data do not address.

Discontinuation & Cycling

  • Duration: Use is open-ended; pattern hair loss is chronic, so any benefit would presumably require continued use, whereas shedding from temporary triggers needs only short-term support.
  • Withdrawal effects: None known. Unlike minoxidil, whose discontinuation sheds drug-dependent hairs within months, no rebound shedding after stopping peppermint oil has been reported.
  • Tapering: Not required; stopping abruptly carries no known physiological consequence.
  • Cycling: No evidence supports cycling for efficacy. Planned breaks have no demonstrated hair benefit, though they reduce cumulative exposure for people with fragrance-sensitive skin.

Sourcing and Quality

  • Species identity: Labels specify Mentha × piperita oil, steam-distilled from aerial parts; cheaper cornmint (Mentha arvensis) oil is sometimes sold as, or blended into, “peppermint oil.”
  • Composition testing: Quality suppliers publish batch GC-MS reports (gas chromatography–mass spectrometry, a chemical fingerprint test) showing menthol about 30–55%, menthone 14–32%, and pulegone within cosmetic-safety limits.
  • Third-party testing: ConsumerLab has tested lavender and tea tree oils but not peppermint oil; independent GC-MS verification is the closest equivalent, since essential oils are not standardized by regulators.
  • Reputable brands: Brands providing lot-specific GC-MS reports, such as Plant Therapy, allow verification; multi-level-marketing brands (doTERRA, Young Living) publish testing but pair it with sales-driven health claims.
  • Pre-made hair products: Commercial peppermint shampoos and serums rarely disclose oil concentration, and many rely on synthetic menthol, making dose comparison with the 3% mouse protocol impossible.
  • Storage: Dark glass, tight caps and cool storage slow oxidation, which increases allergenicity; oil older than 12 months after opening is commonly discarded.

Practical Considerations

  • Time to effect: Human hair cycles mean visible regrowth takes 3–6 months with any topical; rosemary oil and minoxidil showed no hair-count change at 3 months but gains at 6 months (Panahi et al., 2015). Cooling and itch relief are immediate.
  • Common pitfalls: Applying undiluted oil; judging results before 6 months; skipping baseline photographs; treating sudden, patchy or scarring loss without diagnosis; assuming “natural” means allergy-free; replacing approved treatment during rapid progression.
  • Confusion with spearmint: Oral spearmint tea showed anti-androgen effects in women with PCOS (polycystic ovary syndrome, a hormonal disorder) (Grant, 2010); this does not transfer to topical peppermint oil, a different species and route.
  • Regulatory status: In the U.S., peppermint oil is GRAS (generally recognized as safe) as a flavoring and regulated as a cosmetic ingredient; it is not FDA-approved for hair loss, and hair-growth claims would make it an unapproved drug.
  • Cost and accessibility: Inexpensive and widely available; a small bottle lasts months at 1–3% dilution. Insurers rarely cover hair-loss treatment, so no payer incentive favors peppermint oil or approved drugs.

Interaction with Foundational Habits

  • Sleep: None directly. Evening leave-on use is compatible with sleep, but oil transferring to pillowcases can reach the eyes overnight; a towel or cap limits this. Peppermint’s scent is mildly alerting for some people, a minor consideration for application right before bed.
  • Nutrition: Indirect. Peppermint oil does not deplete nutrients, but hair growth depends on adequate protein, iron, zinc and vitamin D; deficiencies blunt any topical effect. Commonly cited targets include protein near 1.2 g/kg daily and iron-rich foods.
  • Exercise: Indirect. Exercise sweat can carry oil into the eyes, so application after workouts avoids irritation. Exercise itself raises circulation, but no additive effect on scalp follicles has been studied.
  • Stress management: Indirect, potentially potentiating. Stress triggers telogen effluvium; the daily massage ritual and scent may support relaxation. Effects on cortisol (the main stress hormone) and on stress-related shedding are unmeasured.

Monitoring Protocol & Defining Success

Baseline testing before starting separates pattern hair loss from shedding caused by treatable deficiencies or thyroid disease, which peppermint oil does not address. Standardized baseline photographs (same lighting, part line and hair length) and, where available, a phototrichogram (a magnified scalp image counting hairs per square centimeter) set the reference point. A 48-hour forearm test with the intended dilution screens for allergy before scalp use.

Ongoing monitoring follows the hair cycle: a skin check at 1 week for rash or irritation, shedding counts and photographs at 3 months, then photographs and hair density at 6 months and every 6 months thereafter. Blood tests are repeated every 6–12 months only if baseline values were abnormal or shedding worsens.

Biomarker Optimal Functional Range Why Measure It? Context/Notes
Ferritin 50–100 ng/mL (hair-focused practitioners often target above 70) Iron stores; low levels drive shedding Conventional range roughly 15–150 ng/mL (women), 30–400 ng/mL (men); inflammation raises ferritin, so pair with CRP (C-reactive protein, an inflammation marker) and CBC (complete blood count); morning fasting draw
TSH 0.5–2.5 mIU/L Screens for thyroid-related shedding TSH = thyroid-stimulating hormone; conventional range about 0.4–4.5 mIU/L; add free thyroxine if abnormal; morning draw
25(OH)D 40–60 ng/mL Low vitamin D is associated with shedding and patchy hair loss 25(OH)D = 25-hydroxyvitamin D, the storage form; conventional range 30–100 ng/mL; no fasting required
Zinc (serum) 90–120 µg/dL Deficiency causes diffuse shedding Conventional range about 60–120 µg/dL; morning fasting draw avoids post-meal dip; check copper if supplementing zinc
Total testosterone and DHEA-S (women) Total testosterone 15–45 ng/dL; DHEA-S 100–250 µg/dL (age-dependent) Detects androgen excess behind female pattern loss DHEA-S = dehydroepiandrosterone sulfate, an adrenal androgen; draw early morning in the early menstrual cycle; conventional ranges are wider
Hair density (phototrichogram) No established target; track change from own baseline Direct measure of regrowth Same marked scalp site, device and magnification each time; no conventional reference range exists

Qualitative markers:

  • Daily shedding count (hairs in brush or shower drain)
  • Hair thickness and volume by feel and ponytail circumference
  • Part-line and crown width on standardized photographs
  • Scalp comfort: itch, burning or tingling duration
  • Scalp redness, flaking or rash
  • Self-rated satisfaction with hair appearance

Emerging Research

  • Registered human trials: A September 2026 ClinicalTrials.gov search found one hair study involving peppermint oil: a hemp-cannabinoid extract with 3% peppermint oil for androgenetic alopecia (NCT04842383; 40 planned participants, early phase 1, hair-count endpoint, status unknown). None tests peppermint oil alone; a trial modeled on Panahi et al., 2015 would test it most directly.
  • Peppermint-containing blends: A 7:3 mastic gum–peppermint extract mixture increased follicle growth factors and hair growth in mice (Ham et al., 2025); its product code (FHH-MG) indicates commercial development. Blend results cannot isolate peppermint’s contribution.
  • Menthol in multi-ingredient scalp products: A 24-week randomized placebo-controlled trial of a heat-treated probiotic formula with menthol, salicylic acid and panthenol raised hair density from 133.7 to 148.9 hairs/cm² in pattern hair loss (Bae et al., 2024); the sponsor was a probiotic company, and menthol’s share is unknown.
  • Cooling-receptor itch science: A randomized human trial controlled against the same gel without active agent found a selective TRPM8-activating gel suppressed itch from several triggers (Lee et al., 2024), strengthening the mechanistic case for peppermint oil in itchy-scalp conditions.
  • Essential oils in alopecia areata: A double-blind trial found a thyme, rosemary, lavender and cedarwood blend improved alopecia areata versus carrier oil (Hay et al., 1998); peppermint was not tested, so this supports the class rather than the oil.
  • Safety evidence that could weaken the case: Twelve-year patch-test data showing 0.6% peppermint allergy with heavy fragrance co-reactivity (Warshaw et al., 2025) and an amended cosmetic safety assessment by an industry-funded panel requiring non-sensitizing formulation (Johnson et al., 2023) set the safety bar any efficacy trial must clear.

Conclusion

Peppermint oil is an inexpensive, widely available essential oil whose main compound, menthol, cools the skin and briefly increases blood flow where it is applied. For adults aiming to slow or reverse hair thinning as part of long-term health, its appeal rests on that blood-flow effect and on animal research in which the diluted oil sped up hair growth.

The evidence stops short of people. No controlled human study has tested peppermint oil on hair counts, hair thickness or shedding, so regrowth remains an idea supported only by animal work and by blood-flow measurements taken on other parts of the body. The strongest human evidence concerns relief of itch and tension headache, which bears on comfort rather than hair growth.

The main risk is skin allergy, which, in data from an independent dermatologist testing network with no stake in peppermint sales, affects a small share of people tested for skin allergies and often overlaps with allergies to other fragrances. Irritation from strong or undiluted oil is the other common problem, while serious internal harm from diluted scalp use appears unlikely.

The evidence base is thin and partly shaped by commercial interests: some animal work on peppermint blends comes from product developers, and a key safety review comes from a panel funded by the cosmetics industry. For this audience, peppermint oil is a low-cost, generally well-tolerated option whose payoff for hair remains unproven, set apart from treatments that have direct human evidence for regrowth.

Top - Benefits - Risks - Protocol